Skip to main content
Erschienen in: Rheumatology International 2/2013

01.02.2013 | Original Article

Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis

verfasst von: Maria Kazakova, Anastas Batalov, Tanya Deneva, Nonka Mateva, Zlatimir Kolarov, Victoria Sarafian

Erschienen in: Rheumatology International | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

YKL-40, also known as human cartilage glycoprotein 39, is a member of the “mammalian chitinase-like proteins” family without chitinase activity. Increased serum concentrations are associated with inflammatory processes and several types of cancer. In this study, we evaluated YKL-40 levels in serum and synovial fluid of patients with rheumatoid arthritis in comparison with the ultrasonographic findings. YKL-40 levels were measured by enzyme-linked immunosorbent assay in 25 patients with active rheumatoid arthritis and in 40 healthy subjects. B mode and power Doppler were performed to determine synovial thickening and vascularization. Serum YKL-40 level in patients was significantly higher than the concentration in healthy controls (P < 0.01). In patients with rheumatoid arthritis, the level of the glycoprotein in synovial fluid was remarkably elevated compared to the serum level (P = 0.003). The B mode and power Doppler scores correlated to YKL-40 in serum and synovial fluid (P = 0.07). Serum YKL-40 levels were related positively to serum markers of inflammation such as C-reactive protein (P = 0.004) and erythrocyte sedimentation rate (P = 0.003). This study is the first to demonstrate a relationship between YKL-40 levels and ultrasonographic examinations in Bulgarian patients with rheumatoid arthritis. The findings suggest that YKL-40 might be implicated in the pathogenesis of the disease and could indicate the level of joint inflammation.
Literatur
1.
Zurück zum Zitat Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209PubMed Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209PubMed
2.
Zurück zum Zitat Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221–225PubMedCrossRef Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221–225PubMedCrossRef
3.
Zurück zum Zitat Roslind A, Johansen JS (2009) YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 511:159–184PubMedCrossRef Roslind A, Johansen JS (2009) YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 511:159–184PubMedCrossRef
4.
Zurück zum Zitat Bojesen SE, Johansen JS, Nostegaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412:709–712PubMedCrossRef Bojesen SE, Johansen JS, Nostegaard BG (2011) Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 412:709–712PubMedCrossRef
5.
Zurück zum Zitat Güngen G, Ardic F, Fιndıkoğlu G, Rota S (2011) The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 31:1–10CrossRef Güngen G, Ardic F, Fιndıkoğlu G, Rota S (2011) The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 31:1–10CrossRef
6.
Zurück zum Zitat Zyvanovic S, Rackov LP, Vojvodic D, Vucetic D (2009) Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis. Int Orthop 33:1165–1170CrossRef Zyvanovic S, Rackov LP, Vojvodic D, Vucetic D (2009) Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis. Int Orthop 33:1165–1170CrossRef
7.
Zurück zum Zitat Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589–595PubMedCrossRef Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211:589–595PubMedCrossRef
8.
Zurück zum Zitat Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M (2008) YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181:5167–5173PubMed Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M (2008) YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181:5167–5173PubMed
10.
Zurück zum Zitat Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95:267–274PubMedCrossRef Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95:267–274PubMedCrossRef
11.
13.
Zurück zum Zitat Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26:47–52PubMedCrossRef Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26:47–52PubMedCrossRef
14.
Zurück zum Zitat Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368PubMed Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368PubMed
15.
Zurück zum Zitat Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M (2001) Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new biomarker for disease activity. Rheumatol Int 20:192–196PubMedCrossRef Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M (2001) Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new biomarker for disease activity. Rheumatol Int 20:192–196PubMedCrossRef
16.
Zurück zum Zitat Mandl P, Naredo E, Wakefield RG, Conaghan PG, D’agostino MA, OMERACT Ultrasound Task Force (2011) A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 38:2055–2062PubMedCrossRef Mandl P, Naredo E, Wakefield RG, Conaghan PG, D’agostino MA, OMERACT Ultrasound Task Force (2011) A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 38:2055–2062PubMedCrossRef
17.
Zurück zum Zitat Schmidt WA, Schmidt H, Schicke B, Cromlica-Ichle E (2004) Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63:988–994PubMedCrossRef Schmidt WA, Schmidt H, Schicke B, Cromlica-Ichle E (2004) Standard reference values for musculoskeletal ultrasonography. Ann Rheum Dis 63:988–994PubMedCrossRef
18.
Zurück zum Zitat Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762–2770PubMedCrossRef Wakefield RJ, Gibbon WW, Conaghan PG, O’Connor P, McGonagle D, Pease C, Green MJ, Veale DJ, Isaacs JD, Emery P (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762–2770PubMedCrossRef
19.
Zurück zum Zitat Naredo E, Bonilla G, Gamero F (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical avaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64:375–381PubMedCrossRef Naredo E, Bonilla G, Gamero F (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical avaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64:375–381PubMedCrossRef
20.
Zurück zum Zitat Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives. Arthritis Rheum 40:598–609PubMedCrossRef Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis. New perspectives. Arthritis Rheum 40:598–609PubMedCrossRef
21.
Zurück zum Zitat Emery P, Gough A, Salmon M, Devlin J (1993) Medical management of rheumatoid arthritis. BMJ 307:425–428CrossRef Emery P, Gough A, Salmon M, Devlin J (1993) Medical management of rheumatoid arthritis. BMJ 307:425–428CrossRef
22.
Zurück zum Zitat Kirwan JR, Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142–147PubMedCrossRef Kirwan JR, Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142–147PubMedCrossRef
23.
Zurück zum Zitat Johansen JS, Jensen HS, Price PA (1993) A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949–955PubMedCrossRef Johansen JS, Jensen HS, Price PA (1993) A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 32:949–955PubMedCrossRef
24.
Zurück zum Zitat Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Østergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRef Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Østergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9:203–214PubMedCrossRef
25.
Zurück zum Zitat Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, Grau K, Nielsen NJ, Ostergaard M (2009) Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomarker Insights 4:91–95PubMed Knudsen LS, Hetland ML, Johansen JS, Skjodt H, Peters ND, Colic A, Grau K, Nielsen NJ, Ostergaard M (2009) Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomarker Insights 4:91–95PubMed
26.
Zurück zum Zitat Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M (1997) Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237:46–54PubMedCrossRef Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M (1997) Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237:46–54PubMedCrossRef
27.
Zurück zum Zitat Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Calafat J, Nielsen HJ, Borregaard N (1998) YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys 110:351–360PubMed Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Calafat J, Nielsen HJ, Borregaard N (1998) YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys 110:351–360PubMed
28.
Zurück zum Zitat Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMed Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810PubMed
29.
Zurück zum Zitat Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6:208–212CrossRef Takahashi M, Naito K, Abe M, Sawada T, Nagano A (2004) Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 6:208–212CrossRef
30.
Zurück zum Zitat Syversen SW, Goll GL, Heijde D, Landeve R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2009) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69:345–351. doi:10.1136/ard.2009.113092 PubMedCrossRef Syversen SW, Goll GL, Heijde D, Landeve R, Lie BA, Odegard S, Uhlig T, Gaarder PI, Kvien TK (2009) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69:345–351. doi:10.​1136/​ard.​2009.​113092 PubMedCrossRef
31.
Zurück zum Zitat Weidekamm C, Koller M, Weber M, Kainberger F (2003) Diagnostic value of high-resolution B-mode and Doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum 48:325–333PubMedCrossRef Weidekamm C, Koller M, Weber M, Kainberger F (2003) Diagnostic value of high-resolution B-mode and Doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum 48:325–333PubMedCrossRef
32.
Zurück zum Zitat Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R (2011) Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 286:15332–15343PubMedCrossRef Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R (2011) Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 286:15332–15343PubMedCrossRef
Metadaten
Titel
Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis
verfasst von
Maria Kazakova
Anastas Batalov
Tanya Deneva
Nonka Mateva
Zlatimir Kolarov
Victoria Sarafian
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 2/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2387-3

Weitere Artikel der Ausgabe 2/2013

Rheumatology International 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.